A Phase 2b Randomized, Double-blind, Active-and Placebo controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Ulcerative Colitis

Project: Research

Project Details

Project Description

NMA/ERM Reference Number: 94697
SSA Reference: SSA/94697/MonH-2023-378579(v2)
Monash Health Reference: RES-23-0000-146X
StatusActive
Effective start/end date15/05/23 → 14/05/28